Skip to Content

TV TV L2 L2 (Lamivudine and zidovudine 150 mg / 300 mg)

Pill imprint TV TV L2 L2 has been identified as Lamivudine and zidovudine 150 mg / 300 mg.

Lamivudine/zidovudine is used in the treatment of occupational exposure; hiv infection; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.